News | Radiation Therapy | January 15, 2016

ASTRO Pledges Support for President’s Commitment to Cancer Research

Society applauds initiative announced in State of the Union address

January 15, 2016 — The American Society for Radiation Oncology (ASTRO) applauded President Obama and Vice President Biden for the “moonshot” effort in cancer research announced in the President’s State of the Union speech on Tuesday.

ASTRO pledged its support of the initiative to bolster resources and foster collaboration among the oncology research community, as well as Vice President Biden’s call in October 2015 to “end cancer as we know it today.”

Despite a two-decade span of decline in cancer death rates, the disease remains a leading source of morbidity and mortality for Americans. The American Cancer Society estimates that nearly 1.7 million Americans will receive cancer diagnoses in 2016, including one in three women and one in two men.

More than half of cancer patients undergo radiation therapy at some point in their treatment, either alone or in conjunction with other treatment options. Existing research demonstrates the effectiveness of radiation therapy as well as its potential in combination with other treatments. ASTRO supports the President’s request to bolster research initiatives that encompass the full range of multidisciplinary therapies in the quest to eradicate cancer.

ASTRO supports research, education and professional training to improve care and outcomes for cancer patients. In 2015 alone, the society provided scientists nearly $1 million through grants and awards supporting radiation oncology research. ASTRO also publishes three medical journals and hosts a variety of scientific meetings in an effort to advance cancer science and help the field avoid the “silos” cautioned in Vice President Biden’s statement, ultimately with the goal of improving patient lives.

For more information: www.astro.org

Related Content

Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...
Videos | Radiation Therapy | August 13, 2018
ITN Editor Dave Fornell takes a tour of some of the innovative new technologies on the expo floor at the 2018 America